Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.04
-0.52 (-9.35%)
Jan 16, 2026, 4:00 PM EST - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $238.06 million as of January 16, 2026. Its market cap has decreased by -26.71% in one year.
Market Cap
238.06M
Enterprise Value
136.05M
1-Year Change
-26.71%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $238.06M, a decrease of -55.78%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 238.06M | -17.11% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.10B |
| Johnson & Johnson | 521.23B |
| AbbVie | 382.90B |
| UnitedHealth Group | 300.28B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 270.17B |
| Novo Nordisk | 262.20B |